過去の関連発表

Shibahara H, Shiroiwa T, Tange C, Nakamura K, Ozono S, Shimozuma K. Reanalysis of cost-effectiveness of abiraterone acetate as second line treatment for metastatic castration-resistant prostate cancer in Japan using a Japanese claim data set. 19th ISPOR Annual International Meeting, 2nd June, 2014, Montreal, QC, Canada.

  • Shibahara H, Shiroiwa T, Tange C, Nakamura K, Ozono S, Shimozuma K. Reanalysis of cost-effectiveness of abiraterone acetate as second line treatment for metastatic castration-resistant prostate cancer in Japan using a Japanese claim data set. 19th ISPOR Annual International Meeting, 2nd June, 2014, Montreal, QC, Canada.